Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,729 | -664 | -1,723 | 15,014 | 11,272 |
| Depreciation Amortization | 1,863 | 1,322 | 652 | 2,723 | 2,086 |
| Income taxes - deferred | 679 | 453 | 226 | 755 | 545 |
| Accounts receivable | 123 | 1,912 | 1,971 | -2,586 | 489 |
| Accounts payable and accrued liabilities | -1,679 | -1,494 | -1,302 | 1,183 | -286 |
| Other Working Capital | -1,719 | -3,260 | -3,331 | -2,809 | -2,894 |
| Other Operating Activity | 10,575 | 6,853 | 3,474 | 12,119 | 7,629 |
| Operating Cash Flow | $13,571 | $5,122 | $-33 | $26,399 | $18,841 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,066 | -8,099 | 2,349 | -7,429 | -3,752 |
| PPE Investments | -2,301 | -1,236 | -711 | -2,836 | -2,072 |
| Purchase Of Investment | -750 | -750 | -750 | N/A | N/A |
| Investing Cash Flow | $-9,117 | $-10,085 | $888 | $-10,265 | $-5,824 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,539 | 5,630 | 1,931 | 3,491 | 3,009 |
| Common Stock Repurchased | -426 | -426 | -426 | -15,045 | -10,892 |
| Other Financing Activity | 0 | 0 | 0 | -257 | 0 |
| Financing Cash Flow | $8,113 | $5,204 | $1,505 | $-11,811 | $-7,883 |
| Exchange Rate Effect | 614 | 428 | -84 | -862 | -367 |
| Beginning Cash Position | 9,451 | 9,451 | 9,451 | 5,990 | 5,990 |
| End Cash Position | 22,632 | 10,120 | 11,727 | 9,451 | 10,757 |
| Net Cash Flow | $13,181 | $669 | $2,276 | $3,461 | $4,767 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,571 | 5,122 | -33 | 26,399 | 18,841 |
| Capital Expenditure | -2,301 | -1,236 | -711 | -2,836 | -2,072 |
| Free Cash Flow | 11,270 | 3,886 | -744 | 23,563 | 16,769 |